Massachusetts technology center houses emerging biotech firms

03/14/2011 | Boston Globe (tiered subscription model), The

The Riverside Technology Center in Cambridge, Mass., accommodates several biotech startups that could become the next Genzyme or Vertex Pharmaceuticals. Among these companies are Bluebird Bio, which is developing gene therapies for rare conditions, and Cerulean Pharma, which is working on a nanoparticle technology that can deliver drugs directly to tumors.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC